The use of chloroquine and hydroxychloroquine for non-infectious conditions other than rheumatoid arthritis or lupus: A critical review

Lupus

Volumn 5, Issue SUPPL. 1, 1996, Pages

  Wallace, D J ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autoimmunity; Chloroquine; Hydroxychloroquine

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE; HYDROXYCHLOROQUINE; PHOSPHOLIPID ANTIBODY;

ARTICLE; CLINICAL TRIAL; DERMATOMYOSITIS; DRUG EFFICACY; DRUG SAFETY; HUMAN; HYPERLIPIDEMIA; PORPHYRIA CUTANEA TARDA; PRIORITY JOURNAL; SARCOIDOSIS; THROMBOEMBOLISM;

EID: 0030011150     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203396005001131     Document Type: Article

References (87)

1. Benyen AC. can chloroquine be of value in the treatment of hypercholesterolemia? Artery 1986; 13: 340-351.
2. Wallace DJ et al. Cholesterol-lowering effect of hydroxychloroquine in patients with rheumatic disease: reversal of deleterious effects of steroids, Amer J Med 1990; 89: 322-326.
3. Hodis HN, Quismorio FP, Wichkam E, Blankenhorn DB. The lipid, lipoprotein and apolipoprotein effects of hydroxychloroquine in patients with systemic lupus erythromatosus, J Rheumatol 1993; 20: 661-65.
4. Blyth TH, McDonald AG, Capell HA, Hunter JA. A comparison of hydroxychloroquine and myocrisin in rheumatoid arthritis (RA); does hydroxychloroquine have a favorable effect on the blood lipid profile? Brit J Rheumatol 1994; 33 (Suppl.): 149.
5. Powrie JK et al. Effects of chloroquine on the dyslipidemia of non-insulin dependent diabetes mellitus, Metabolism 1993; 42: 415-419.
6. Powrie JK, Watts GF, Sonksen PH, Jones RH. Short-term effects of mepacrine on serum lipids, liproproteins, and apolipoproteins in patients with non-insulin-dependent diabetes mellitus, Metabolism 1994; 43: 131-134.
7. Petri M, Lakatta C, Magdar L, Goldman D. Effect of prednisone and hydroxychloroquine on coronary artery disease risk factors in systemic lupus erythematosus: A longitudinal data analysis, Amer J Med 1994; 96: 254-259.
8. Jancinova V, Nosal R, Pterikova M. On the inhibitory effect of chloroquine on blood platelet aggregation. Thromb Res 1994; 74: 495-504.
9. Cecchi E, Ferraris E. Desludging action of hydroxychloroquine in rheumatoid arthritis. Acta Rheum Scand 1962; 8: 214-221.
10. Loudon JR. Hydroxychloroquine and postoperative thromboembolism after total hip replacement. Amer J Med 1988; 84 (Supp. 4A): 57-61.
11. Wallace DJ. Does hydroxychloroquine sulfate prevent clot formation in systemic lupus erythematosus? Arthritis Rheum 1987; 30: 1435-1436.
12. Wallace DJ, Linker-Israeli M, Metzger AL, Stecher VJ. The relevance of antimalarial therapy with regard to thrombosis, hypercholesterolemia and cytokines in SLE, Lupus 1993; 2: S13-S15.
13. Petri M et al. Arterial thrombotic events (TE) in SLE: The Baltimore Lupus Cohort Study, Arthritis Rheum 1994; 37: S297.
14. Sheffer B, Cahn MM, Levy EJ. Sarcoidosis apparently cured by quinacrine (Atabrine) hydrochloride, Arch Dermatol Syph 1953; 67: 640-641.
15. Zic JA, Horowitz DH, Arzubiaga C, King LE. Treatment of cutaneous sarcoidosis with chloroquine. Arch Dermatol 1991; 127: 1034-1040.
16. Morse SI, Crohn ZA, Hirsch JG, Shaedler RW. The treatment of sarcoidosis with chloroquine. Amer J Med 1961; 30: 779-784.
17. Hirsch JG. Experimental treatment with chloroquine. Am Rev Respir Dis 1961; 84: 52-58.
18. Davies D. Sarcoidosis treated with chloroquine. Br J Dis Chest 1963; 57: 30-36.
19. Siltzbach LE, Teirstein AS. Chloroquine therapy in 43 patients with intrathoracic and cutaneous sarcoidosis. Acta Med Scand 1964; 176 (Suppl. 425): 302-308.
20. Morse SI. The therapeutic effect of chloroquine in sarcoidosis, In: Turiaf J, Chabot J (eds). La Sarcoidoise: Rapports de la IV Conference International, Paris, France. Mason & Co, 1967; 755-771.
21. British Tuberculosis Association. Chloroquine in the treatment of sarcoidosis: a report of the research committee of the British Tuberculosis Association, Tubercle 1967; 48: 257-272.
22. Brodthagen H, Glig I. Hydroxychloroquine in the treatment of sarcoidosis. In: Tyriaf J, Chabot J eds). La Sarcoidoise: Rapports de la IV Conference International, Paris, France. Mason & Co, 1967: 764-767.
23. Johns CJ et al. Longitudinal study of chronic sarcoidosis with low-dose maintenance corticosteroid therapy: outcome and complications, Ann NY Acad Sci 1986; 465: 702-712.
24. Jones E, Callen JP. Hydroxychloroquine in effective therapy for control of cutaneous sarcoidal granuloma, J Am Acad Dermatol 1990; 23: 487-489.
25. Abu-Skakra M, Lee P, Hypoglycemia: an unusual adverse reaction to chloroquine. Clin Exper Rheumatol 1994; 11: 95-96.
26. White NJ et al. Hypoglycemia in african children with severe malaria. Lancet 1987; 1: 708-711.
27. Quartaro A, Consoli G, Ceriello A, Giugliano D. Is there a role of chloroquine treatment in diabetes? A three case report. Diabete & Metabolisme 1988; 14: 666-667.
28. Quartaro A et al. Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes. An old job for a new drug? Annals Intern Med 1990; 112: 678-681.
29. Powrie JK et al. Mode of action of chloroquine in patients with non-insulin dependent diabetes mellitus. Am J Physiol 1991; 260 (6 Pt 1): E897-E904.
30. Petri M, Ferman D, Goldman D. Hypoglycemic effect of hydroxychloroquine in systemic lupus erythematosus. Arthritis Rheum 1994; 37: R24.
31. Cainelli T et al. Hydroxychloroquine versus phlebotomy in the treatment of porphyria cutanea tarda, Brit J Dermatol 1983; 108: 593-600.
32. Peterson CS, Thomsen K. High-dose hydroxychloroquine treatment of porphyria cutanea tarda. J Amer Acad Dermatol 1992; 26: 614-619.
33. Valls V, Ena J, Enriquez-de Salmanca R. Low-dose oral chloroquine with porphyria cutanea tarda. J Dermatol Sci 1994; 7: 169-175.
34. Geschicter CF. Quinoline therapy in asthma. Southern Med J 1955; 48: 497-509.
35. Goldstein JA. Hydroxychloroquine in asthma. Amer Rev Resp Dis 1983; 128: 1100-1101.
36. Charous BL. Open study of hydroxychloroquine in the treatment of severe symptomatic or corticosteroid-dependent asthma. Annals Allergy 1990; 65: 53-58.
37. Fox RI et al. Treatment of primary Sjogren's syndrome with hydroxychloroquine. Amer J Med 1988; 85 (Suppl. 4A): 62-67.
38. Kruize AA et al. Hydroxychloroquine treatment for primary Sjogren's syndrome: a two year double blind crossover trial. Annals Rheum Dis 1993; 52: 360-364.
39. Murphy GM, Hawk JL, Magnus JA. Hydroxychloroquine in polymorphic light eruption: a controlled trial with drug and visual sensitivity monitoring. Brit J Deramtol 1987; 116: 379-386.
40. Parrow A, Samuelsson S-M. Chloroquine for leg cramps. Acta Med Scand 1967; 181: 237-244.
41. Sever MS, Kocak N. Chloroquine phosphate reduces the frequency of muscle cramps during maintenance hemodialysis. Nephron 1990; 56: 441.
42. Rothschild BM. Prospective six month, double-blind trial of Plaquenil treatment of calcium pyrophosphae (sic) deposition disease (CPPD), Arthritis Rheum 1994; 37: S414.
43. Doring H-F, Mullejans-Kreppel U. Treatment of atopic dermatitis with chloroquine. Z Hautkr 1987; 62: 1205-1213.
44. Smith KC. Hydroxychloroquine is useful in the management of atopic dermatitis. Brit J Dermatol 1992; 126: 93-94.
45. Eisen D. Hydroxychloroquine sulfate (Plaquenil) improves oral lichen planus: An open trial. J Amer Acad of Dermatol 1993; 28: 609-612.
46. Allbers SE, Glass LF, Fenske NA. Lichen planus subtropicus: Direct immuaofluorescence and therapeuric response to hydroxychloroquine. Inter J Dermatol 1994; 33: 645-647.
47. Wakelin SH, James MP. Extensive lichen sclerosis et atrophicus with bullae and ulceration - improvement with hydroxychloroquine. Clin Exper Dermatol 1994; 19: 332-334.
48. Carlin MC, Ratz JL. A case of generalized granuloma annulare responding to hydroxychloroquine. Cleveland Clin J Med 1967; 54: 229-232.
49. Cleveland Clin J Med 1968; 55: 117.
50. Sayers ME, Mazanec DJ. Use of antimalarial drugs for the treatment of psoriatic arthritis. Amer J Med 1992; 93: 474-475.
51. Kuflik EG. Effect of antimalarial drugs on psoriasis. Cutis 1980; 26: 153-155.
52. Kammer GM, Soter NA, Gibson DJ, Schur PH. Psoriatic arthritis: a clinical, immunologic and HLA study of 100 patients. Semin Arthritis Rheum 1979; 9: 75-97.
53. Le Guennec P et al. Management of giant cell arteritis. Value of synthetic antimalarial agents, A retrospective study of 36 patients. Rev Rhum (Eng Ed) 1994; 61: 423-428
54. Woo TY et al. Cutaneous lesions of dermatomyositis are improved by hydroxychloroquine. J Am Acad Dermatol 1984; 10: 592-600.
55. James W, Dawson N, Rodman O. The treatment of dermatomyositis with hydroxychloroquine. J Rheumatol 1985; 12: 1214-1216.
56. Bloom BJ et al. Worsening of the rash of juvenile dermatomyositis with hydroxychloroquine therapy. J Rheumatol 1994; 21: 2171.
57. Olson NY, Lindsley CB. Adjunctive use of hydroxychloroquine in childhood dermatomyositis. J Rheumatol 1989; 16: 1545-1547.
58. Olson NY, Lindsley CB. Drs Olson and Lindsley reply. J Rheumatol 1994; 21: 2171-2172.
59. Youssef W, Yan A, Russell AS. Palindromic rheumatism: A response to chloroquine. J Rheumatol 1991; 18: 35-37.
60. Golding DN. D-pencillamine in palindromic rheumatism. Brit Med J 1976; 2: 1382-1383.
61. Mattingley S et al. Palindromic rheumatism. J R Coll Phys 1981; 15: 119-123.
62. Hannonen P, Mottonen T, Oka M. Palindromic rheumatism, a survey of 60 patients. Scand J Rheumatol 1967; 16: 413-420.
63. McKay J, Cervantes A, Singleton PT Jr. Hydroxychloroquine sulfate: An effective alternative in treating palindromic rheumatism. Arthritis Rheum 1981; 24: S70.
64. Robertson CR, Rice JR, Allen NB. Treatment of erosive osteoarthritis with hydroxychloroquine. Arthritis Rheum 1993; 36: S167.
65. Bryant LR, des Rosier KF, Carpenter MT. Hydroxychloroquine in the treatment of erosive osteoarthritis. J Rheumatol 1995; 22: 1527-1531.
66. Bush A, Sheppard MN, Warner JO. Chloroquine in idiopathic pulmonary hemosiderosis. Arch Dis Childhood. 1992; 67: 625-627.
67. Leahy F, Pasterkamp H, Tal A. Desquamative interstitial pneumonia responding to chloroquine. Clin Pediatrics 1985; 24: 230-232.
68. Walters KA, Bale P, Isaacs D, Mellis C. Successful chloroquine therapy in a child with lymphoid interstitial pneumonitis. J Periatr 1991; 119: 989-991.
69. Campos JM, Simonetti JP. Treatment of lymphoid interstitial pneumonia with chloroquine. J Pediatrics 1993; 122: 503.
70. Sharlef N, Crawford DF, Dinwiddie R. Fibrosing alveolitis and desquamative interstitial pneumonitis. Pediatr Pulmonol 1994; 17: 359-365.
71. Springer C et al. Chloroquine treatment of desquamative interstitial pneumonia. Arch Dis Child 1987; 62: 76-77.
72. Ochonisky S et al. Granulomatous cheilitis as a cutaneous extension of Crohn's disease responds to hydroxychloroquine. Ann Dermatol Venereal 1992; 119: 844-846.
73. Louis E, Belaiche J. Hydroxychloroquine (Plaquenil) for recurrence prevention of Crohn's disease after curative surgery. Gastroenterol Clin Biol 1995; 19: 233-234.
74. Adams JS, Diz BS, Sharma OP. Effective reduction in the serum 1, 25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcaemia with short-course chloroquine therapy. Annals Intern Med 1989; 111: 437-438.
75. Datar SA, Priess JR. Hydroxychloroquine in the treatment of hypercalcemia secondary to disseminated coccidiomycosis. Clin Res 1994; 42: A17.
76. O'Leary TJ et al. The effects of chloroquine on serum 1, 5-dihydroxyvitamin D and calcium metabolism in sarcoidosis. N Engl J Med 1986; 315: 727-730.
77. Barre PE, Gascon-Bavre M, Meakins JL, Goltzman D. Hydroxychloroquine treatment of hypercalcemia in a patient with sarcoidosis undergoing hemodialysis. Amer J Med 1987; 82: 1259-1262.
78. Hauben M. Quinacrine and chronic fatigue syndrome. Amer Fam Phys 1994; 49. 1354.
79. Stoll DM. Treatment of cutaneous pseudolymphoma with hydroxychloroquine. J Amer Acad Dermatol 1983; 8: 696-699.
80. Drenou B, Guyader D, Turlin B, Fauchet R. Treatment of side-roblastic anemia with chloroquine. N Engl J Med 1995; 332: 614.
81. Coblyn JS, Taylor P. Treatment of chronic lyme arthritis with hydroxychloroquine. Arthritis Rheum 1981; 24: 1567-1569.
82. Lopez LR, Davis KC, Kohler PF, Schocket AL. The hypocomplementemic urticarial-vasculitis syndrome: Their response to hydroxychloroquine. J Allergy Clin Immunol 1984; 73: 600-603.
83. Balogh E, Nagy-Vezekenyi K, Forizs E. REM syndrome: An immediate therapeuric response to hydroxychloroquine sulphate. Acta Derm Venereol 180; 60: 173-175.
84. Hymes SR, Jordon RE. Pemphigus foliaceus. The use of antimalarial agents as adjuvant therapy. Arch Dermatol 1992; 128: 1462-1464.
85. Purcell JJ. Hydroxychloroquin (sic) and chronic sinusitis. Conn Med 1990; 54: 694.
86. Brawer AE. Anarthritic rheumatoid arthritis: The polymyalgia dilemma. Arthritis Rheumatism 1991; 34: S179.
87. Mayer L. Personal communication from Sanofi Winthrop.